商务合作
动脉网APP
可切换为仅中文
Expanding Innovation Portfolio to Support Delivering Hearing to Patients in Innovative Ways WHITE BEAR LAKE, Minnesota, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that it recently has been awarded three additional patents.
2024年1月22日,明尼苏达州白熊湖(Global NEWSWIRE)——Envision Medical®,Inc.(“Envision Medical”)(纳斯达克:“COCH”),一家专注于全植入听力系统的革命性听力健康公司,今天宣布,它最近又获得了三项专利。
These patents are further evidence of Envoy Medical’s determination to be an innovation leader in hearing health to benefit patients with significant hearing loss. The patents are as follows: The US Patent & Trademark Office issued Envoy Medical Corporation US Pat. No. 11,839,765 on December 12, 2023.
这些专利进一步证明了Envision Medical决心成为听力健康领域的创新领导者,以造福患有严重听力损失的患者。专利如下:美国专利商标局(US Patent&Trademark Office)发布了Envision Medical Corporation US Pat。2023年12月12日第11839765号。
The title of the patent is Cochlear Implant System with Integrated Signal Analysis Functionality. The US Patent & Trademark Office issued Envoy Medical Corporation US Pat. No. 11,865,339 on January 9, 2024. The title is Cochlear Implant System with Electrode Impedance Diagnostics. The European Patent Office granted European Pat.
该专利的标题是具有集成信号分析功能的人工耳蜗系统。美国专利商标局发布了美国特使医疗公司专利。2024年1月9日第11865339号。标题是带有电极阻抗诊断的人工耳蜗系统。欧洲专利局授予欧洲专利。
No. 3927420 on January 10, 2024. The title is Implantable Cochlear System with Integrated Components and Lead Characterization. “Investors, patients, and industry professionals may notice that Envoy Medical continues to steadily grow its intellectual property portfolio as we reaffirm our commitment to the hearing industry and to providing patients with innovative hearing solutions,” said Brent Lucas, Envoy Medical’s Chief Executive Officer.
2024年1月10日第3927420号。标题是具有集成组件和铅表征的植入式耳蜗系统。特使医疗首席执行官布伦特·卢卡斯(Brent Lucas)表示:“投资者、患者和行业专业人士可能会注意到,随着我们重申对听力行业和为患者提供创新听力解决方案的承诺,特使医疗继续稳步增长其知识产权组合。”。
“We expect 2024 to be an exciting year with a number of milestones, including the next phase of the clinical investigation of our fully implanted cochlear implant system. We believe our system’s design will allow us an opportunity to separate ourselves from others and provide patients with a new hearing option.” About Envoy Medical Envoy Me.
“我们预计2024年将是激动人心的一年,将有许多里程碑式的进展,包括我们的全植入人工耳蜗系统的下一阶段临床研究。我们相信,我们的系统设计将使我们有机会与他人分开,并为患者提供新的听力选择。”关于特使医疗特使我。